Fresenius Medical Care AG (FMS) Cash from Investing Activities (2010 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Cash from Investing Activities data on file, last reported at -$486.8 million in Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 282.22% year-over-year to -$486.8 million; the TTM figure through Dec 2025 stood at -$824.6 million (down 760.6% YoY), while the FY2025 annual figure was -$841.1 million, down 826.63% from the prior year.
• Cash from Investing Activities declined to -$486.8 million in Q4 2025, from -$63.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $347.4 million in Q2 2024 and bottomed at -$486.8 million in Q4 2025.
• A 5-year average of -$184.8 million and a median of -$169.9 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 339.22% — and 2025, when it slumped 282.22%.
• Year by year, Cash from Investing Activities stood at -$483.7 million in 2021, then jumped by 52.55% to -$229.5 million in 2022, then jumped by 54.76% to -$103.8 million in 2023, then dropped by 22.67% to -$127.4 million in 2024, then slumped by 282.22% to -$486.8 million in 2025.
• The last three Cash from Investing Activities figures came in at -$486.8 million (Q4 2025), -$63.1 million (Q3 2025), and -$160.8 million (Q2 2025), per Business Quant data.

Peer Comparison